Skip to navigation menu Skip to content
Informational Alert

Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

High Priority Alert

Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines .

Illustration of a calendarIllustration of a document pageIllustration of a heart over a handIllustration of an envelopeIllustration of the letter i inside a circleIllustration of a map markerIllustration of a caduceusIllustration of a user with a plus signIllustration of a telephoneIllustration of a question mark inside a circleIllustration of a video cameraDocument with a PDF label
Current Research Studies

PEDIATRIC AND YOUNG ADULT LEUKEMIA ADOPTIVE THERAPY (PLAT)-07: A PHASE 1/2 STUDY OF CD22-SPECIFIC CAR T CELLS FOR CD22+ LEUKEMIA OR LYMPHOMA

PLAT-07

What is the goal of the study?

This phase 1/2, open-label, non-randomized study will enroll pediatric and young adult research participants with relapsed or refractory CD22+ leukemia or lymphoma with and without prior history of allogeneic hematopoietic stem cell transplantation, to examine the safety, feasibility, and efficacy of administering T cell products derived from autologous peripheral blood mononuclear cells (PBMC) that have been genetically modified using a self-inactivating SIN lentiviral vector to express a CD22-specific chimeric antigen receptor (CAR), and the selection-suicide marker EGFRt (SCRI-CAR22v2).

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: